• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION SD ALARIS SYSTEM; PUMP, INFUSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION SD ALARIS SYSTEM; PUMP, INFUSION Back to Search Results
Model Number 8120
Device Problems Inaccurate Delivery (2339); Charging Problem (2892); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Respiratory Insufficiency (4462)
Event Date 10/08/2021
Event Type  Injury  
Manufacturer Narrative
The event logs have been received and the evaluation is pending.A follow up report will be submitted with investigation results once the evaluation has been completed.Per 803.52(f)(11)(iii) the information provided represents all of the known information at this time.The complainant or reporter was unable or unwilling to provide any further patient, product, or procedural details to the manufacturer.No devices received, log review only.
 
Event Description
It was reported that a pca infusion error occurred wherein a patient received about 5 mg of hydromorphone, which was confirmed through visual inspection by nursing staff.However per hospital pharmacist's review of infusion knowledge portal data, about only 0.6 to 1mg of the medication was delivered via pca syringe pump.Pca module was programmed as pca dose only and the total dose concentration of the medication was hydromorphone 30mg/30ml.There was patient involvement and the issue resulted in over sedation/respiratory depression.The patient received a reversal agent and recovered.
 
Event Description
It was reported that a pca infusion error occurred wherein a patient received about 5 mg of hydromorphone, which was confirmed through visual inspection by nursing staff.However per hospital pharmacist's review of infusion knowledge portal data, about only 0.6 to 1mg of the medication was delivered via pca syringe pump.Pca module was programmed as pca dose only and the total dose concentration of the medication was hydromorphone 30mg/30ml.There was patient involvement and the issue resulted in over sedation/respiratory depression.The patient received a reversal agent and recovered.
 
Event Description
It was reported that a pca infusion error occurred wherein a patient received about 5 mg of hydromorphone, which was confirmed through visual inspection by nursing staff.However per hospital pharmacist's review of infusion knowledge portal data, about only 0.6 to 1mg of the medication was delivered via pca syringe pump.Pca module was programmed as pca dose only and the total dose concentration of the medication was hydromorphone 30mg/30ml.There was patient involvement and the issue resulted in over sedation/respiratory depression.The patient received a reversal agent and recovered.
 
Event Description
It was reported that a pca infusion error occurred wherein a patient received about 5 mg of hydromorphone, which was confirmed through visual inspection by nursing staff.However per hospital pharmacist's review of infusion knowledge portal data, about only 0.6 to 1mg of the medication was delivered via pca syringe pump.Pca module was programmed as pca dose only and the total dose concentration of the medication was hydromorphone 30mg/30ml.There was patient involvement and the issue resulted in over sedation/respiratory depression.The patient received a reversal agent and recovered.
 
Manufacturer Narrative
Omit: a140504 - inaccurate delivery (2339), c20 - no findings available, b17 - device not returned.A device history record review is performed on each device reported in a mdr reportable event along with other methods of investigation as coded in section h6 of this mdr report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALARIS SYSTEM
Type of Device
PUMP, INFUSION
Manufacturer (Section D)
CAREFUSION SD
10020 pacific mesa blvd
san diego CA 92121 4386
Manufacturer Contact
brett wilko
10020 pacific mesa blvd
san diego, CA 92121-4386
8586172000
MDR Report Key12743402
MDR Text Key279773842
Report Number2016493-2021-68878
Device Sequence Number1
Product Code MEA
UDI-Device Identifier10885403812002
UDI-Public(01)10885403812002
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K043299
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,Company Representative
Reporter Occupation Pharmacist
Remedial Action Recall
Type of Report Initial,Followup,Followup,Followup
Report Date 05/11/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/03/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number8120
Device Catalogue Number8120 ALARIS PCA MODULE
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/05/2022
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/14/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/15/2018
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Removal/Correction NumberZ-1520-2017
Patient Sequence Number1
Treatment
8015; 8100; 8210; 8300; 8015
Patient Outcome(s) Required Intervention;
Patient Age91 YR
Patient SexMale
Patient Weight87 KG
-
-